About Biocon
Biocon is a company based in Bengaluru (India) founded in 1978 by Kiran Mazumdar Shaw. The company has 4,020 employees as of April 08, 2024. Biocon has completed 2 acquisitions, including Axicorp and Nobex Corp. Biocon offers products and services including Biosimilars and Generics.
- Headquarter Bengaluru, India
- Employees 4020 as on 08 Apr, 2024
- Founders Kiran Mazumdar Shaw
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biocon Limited
-
Annual Revenue
$1.78 B (USD)3.45as on Mar 31, 2024
-
Net Profit
$118.34 M (USD)-0.9as on Mar 31, 2024
-
EBITDA
$389.6 M (USD)-20.59as on Mar 31, 2024
-
Latest Funding Round
$300 M (USD), Post-IPO
Apr 25, 2023
-
Investors
Goldman Sachs
& 5 more
-
Employee Count
4020
as on Apr 08, 2024
-
Investments & Acquisitions
Axicorp
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Biocon
Biocon is a publicly listed company on the NSE with ticker symbol BIOCON in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Biocon
Biocon offers a comprehensive portfolio of products and services, including Biosimilars and Generics.
Biosimilars are developed as cost-effective alternatives to biologic drugs for various therapeutic areas
Generics are manufactured for key therapeutic areas to provide affordable medication options
People of Biocon
Unlock access to complete
Unlock access to complete
Leadership Team
62 people
Software Development Team
13 people
Product Management Team
10 people
Head Team
7 people
Human Resources and Administration
7 people
Sales and Marketing
6 people
Senior Team
5 people
Operations Team
5 people
Unlock access to complete
Funding Insights of Biocon
Investors in Biocon
Biocon has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Goldman Sachs, Kotak Mahindra Bank and Tata Capital Growth Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
ADQ is recognized as a leading sovereign investor focused on sustainable economic transformation in Abu Dhabi.
|
Locked | Locked | Locked | |
|
Investment banking services are delivered across multiple financial sectors.
|
Locked | Locked | Locked | |
|
Growth capital fund sponsored by the Tata group, focusing on investments and portfolio management.
|
Locked | Locked | Locked |
Investor details for Biocon
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biocon
Biocon has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Axicorp and Nobex Corp.
Investment portfolio details for Biocon
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OTC drugs are manufactured by Axicorp in Germany.
|
Locked | Locked | 2002 | Locked | |
|
Blog on legal & personal attorney related topics
|
Locked | Locked | 1993 | Locked |
Complete acquisition details for Biocon
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Biocon
Detailed financials for Biocon
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biocon Comparisons
Peer comparison for Biocon
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biocon
Detailed competitors of Biocon
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biocon
Complete news archive for Biocon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biocon
Biocon was founded in 1978 and raised its 1st funding round 25 years after it was founded.
Biocon is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Siddharth Mittal is the current CEO of Biocon.
As of Apr 08, 2024, the latest employee count at Biocon is 4,020.
Annual revenue of Biocon is $1.78B as on Mar 31, 2024.
Biocon was founded in 1978 in Bengaluru, India, within the biotechnology sector. Drug research and development services are offered across various therapeutic areas. Additional operations include research on gene therapy, API development, generic formulations, quality control, and scientific services. The company supports pharmaceutical innovation through these specialized offerings in the Indian market.
Biocon offers Biosimilars and Generics.
Yes, Biocon is publicly traded on NSE under the ticker symbol BIOCON.
Biocon has made 2 acquisitions, including Axicorp, and Nobex Corp.
Biocon has 6 investors. Key investors include Goldman Sachs, Kotak Mahindra Bank, Tata Capital Growth Fund, Serum Life Sciences, and ADQ.
The ticker symbol of Biocon is BIOCON on NSE.